Thabit Abrar K, Fairaq Ebtihal M, Almutairi Fahdah S
Pharmacy Practice Department, Faculty of Pharmacy, King Abdulaziz University, Jeddah, KSA.
Pharmacy Department, King Fahad Armed Forces Hospital, Jeddah, KSA.
J Taibah Univ Med Sci. 2022 Sep 16;18(1):26-31. doi: 10.1016/j.jtumed.2022.08.012. eCollection 2023 Feb.
Surgical site infections (SSIs) develop within 30-90 days postoperatively. Antibiotic prophylaxis helps reduce SSI incidence, with cefazolin being the most used agent. Current guidelines recommend against postoperative antibiotic administration or a very short course. This study evaluated the appropriateness of prophylactic antibiotics by surgery type, as well as duration and their impact on SSI incidence.
This was an observational prospective study of adults admitted between June and October 2019 for abdominal or orthopedic surgery who received prophylactic antibiotics. The primary endpoint was compliance of postoperative prophylactic antibiotic duration with the guidelines. Secondary endpoints included appropriateness of antibiotic choice and SSI rates.
Of the 98 patients, 59, 23, and 16 had orthopedic, upper abdominal, and lower abdominal surgery, respectively. Median postoperative antibiotic durations were longer in the abdominal surgery group than in the orthopedic surgery group (7 vs. 5 days; = 0.03). Hence, overall compliance with the guidelines in terms of postoperative antibiotic duration was 11.2% (13.6%, 13%, and 0% in each surgery group, respectively; = 0.3). Conversely, antibiotic choice was highly compliant with the guidelines at 71.4% (72.9%, 65.2%, and 75% in each surgery group, respectively; = 0.74). This was significantly associated with a lower risk of SSIs (odds ratio 0.24, 95% confidence 0.09-0.63).
While there was a lack of guidelines compliance in terms of duration, appropriateness of antibiotic choice was high and was associated with a lower likelihood for SSIs. Clinicians are encouraged to follow the guidelines to improve patients' quality of care by preventing SSIs and reducing the risk of antimicrobial resistance development.
手术部位感染(SSIs)在术后30 - 90天内发生。抗生素预防有助于降低手术部位感染的发生率,头孢唑林是最常用的药物。当前指南不建议术后使用抗生素或仅使用极短疗程。本研究评估了不同手术类型预防性使用抗生素的合理性、使用时长及其对手术部位感染发生率的影响。
这是一项对2019年6月至10月因腹部或骨科手术入院并接受预防性抗生素治疗的成年人进行的前瞻性观察研究。主要终点是术后预防性抗生素使用时长是否符合指南。次要终点包括抗生素选择的合理性和手术部位感染率。
98例患者中,分别有59例、23例和16例接受了骨科手术、上腹部手术和下腹部手术。腹部手术组术后抗生素使用的中位时长比骨科手术组长(7天对5天;P = 0.03)。因此,术后抗生素使用时长总体符合指南的比例为11.2%(各手术组分别为13.6%、13%和0%;P = 0.3)。相反,抗生素选择高度符合指南,比例为71.4%(各手术组分别为72.9%、65.2%和75%;P = 0.74)。这与手术部位感染风险较低显著相关(优势比0.24,95%置信区间0.09 - 0.63)。
虽然在使用时长方面缺乏对指南的依从性,但抗生素选择的合理性较高,且与手术部位感染可能性较低相关。鼓励临床医生遵循指南,通过预防手术部位感染和降低抗菌药物耐药性发展风险来提高患者的医疗质量。